Literature DB >> 25444717

The female condom learning curve: patterns of female condom failure over 20 uses.

Mags Beksinska1, Jenni Smit2, Ross Greener3, Gilda Piaggio4, Carol Joanis5.   

Abstract

BACKGROUND: Male and female condom (FC) functional performance failure declines with user experience. With the recent availability of a wider range of FCs, it is important to know if women with experience in using one type of FC are more proficient in using another type, even if the FC design is quite different. STUDY
DESIGN: A randomized, noninferiority crossover clinical trial assessed the function of four FCs (FC2, Woman's Condom, Cupid and VA w.o.w) among 300 women in Durban, South Africa. FC functional failure (breakage, slippage, invagination and misdirection) by condom type and use period was investigated in women using five FCs of each type (20 FC uses in total).
RESULTS: Of the 5364 condoms used during intercourse by 272 women, 200 clinical failures occurred in 195 condoms (190 condoms had one failure, and 5 had two failures). Total clinical failure was comparable across FC types. Of the 195 condoms in which failures occurred, the number of failures in the first condom use period was 103 (7.7%), decreasing to 43 events (3.2%) in the second, 33 (2.5%) in the third and 16 (1.2%) in the fourth. Only 2 failures were reported in the 20th use of an FC compared to 29 in the first use, irrespective of condom type.
CONCLUSIONS: FC failure rates decreased markedly after use of the first five condoms regardless of FC type and continued to fall across the next three use periods. IMPLICATIONS: FC failure rates decrease over 20 uses, regardless of FC condom type used. The decrease is higher at the beginning of use, indicating that improvement is greatest after the first five uses.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Barrier methods; Experience; Female condom; Function

Mesh:

Year:  2014        PMID: 25444717     DOI: 10.1016/j.contraception.2014.09.011

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  6 in total

1.  Acceptability of the Woman's Condom in a phase III multicenter open-label study.

Authors:  Beatrice A Chen; Diana L Blithe; Gitonga R Muraguri; Audrey A Lance; Bruce R Carr; Jeffrey T Jensen; Thomas D Kimble; Amitasrigowri S Murthy; Courtney A Schreiber; Michael A Thomas; Terri L Walsh; Carolyn Westhoff; Anne E Burke
Journal:  Contraception       Date:  2019-03-06       Impact factor: 3.375

2.  Short-term acceptability of female condom use among low-fee female sex workers in China: a follow-up study.

Authors:  Chu Zhou; Evelyn Hsieh; Keming Rou; Jonas Tillman; Wei Dong; Xian-Xiang Feng; Yan-Zhen Yang; Yu-Jun Yang; Xian-Guo Sun; Hai-Jian Zang; Ying-Zhen Wu; Zunyou Wu
Journal:  BMC Womens Health       Date:  2019-06-14       Impact factor: 2.809

3.  Short-Term Acceptability of the Woman's Condom among Married Couples in Shanghai.

Authors:  Junqing Wu; Zirong Huang; Patricia S Coffey; Maggie Kilbourne-Brook
Journal:  J Sex Transm Dis       Date:  2016-07-28

Review 4.  Knowledge, attitudes, practices and behaviors associated with female condoms in developing countries: a scoping review.

Authors:  Lizzie Moore; Mags Beksinska; Alnecia Rumphs; Mario Festin; Erica L Gollub
Journal:  Open Access J Contracept       Date:  2015-09-21

5.  Performance and Acceptability of the FC2 Female Condom When Used With and Without a Silicone Placebo Vaginal Ring-A Randomized, Crossover Trial.

Authors:  Annalene Nel; Mariëtte Malherbe; Neliëtte van Niekerk; Mags Beksinska; Ross Greener; Jennifer Smit; Ron Frezieres; Terri Walsh
Journal:  J Acquir Immune Defic Syndr       Date:  2020-09-01       Impact factor: 3.771

6.  Spanish validation of female condom attitude scale and female condom use in Colombian young women.

Authors:  Vallejo-Medina Pablo; Ramírez Carlos Eduardo; Saavedra-Roa Diego Alejandro; Gómez-Lugo Mayra; Pérez-Durán Claudia
Journal:  BMC Womens Health       Date:  2019-10-28       Impact factor: 2.809

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.